{
    "code": "51059239",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51059239",
    "time": "2018-10-12 03:39:11",
    "許可證字號": "衛部藥製字第059239號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/07\/19",
    "發證日期": "105\/07\/19",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY05105923901",
    "中文品名": "癌必莎爾膜衣錠250毫克",
    "英文品名": "Ternibin F.C. Tablets 250mg",
    "適應症": "Gefitinib適用於具有EGFR-TK突變之局部侵犯性或轉移性之非小細胞肺癌(NSCLC)病患之第一線治療。Gefitinib適用於先前已接受過化學治療後，但仍局部惡化或轉移之肺腺癌病患之第二線用藥。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠塑膠瓶裝 2-1000錠PTP 鋁箔盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "GEFITINIB"
    ],
    "限制項目": "01國　產 24監視期滿學名藥 61完成BE試驗",
    "申請商名稱": "0402601200  中國化學製藥股份有限公司新豐工廠",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "0402602300  中國化學製藥股份有限公司新豐工廠",
        "製造廠廠址": "新竹縣新豐鄉坑子口１８２之１號",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000600",
            "成分名稱": "GEFITINIB",
            "含量描述": "",
            "含量": "250.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Ternibin F.C. Tablets 250 mg In-105-08-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059239&Seq=001&Type=9"
        },
        {
            "title": "Ternibin F.C. Tablets 250 mg Box-105-08-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059239&Seq=002&Type=8"
        }
    ]
}